CSAM Health Group AS
CSAMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,107 | $1,000 | $986 | $890 |
| - Cash | $122 | $117 | $192 | $275 |
| + Debt | $483 | $477 | $494 | $491 |
| Enterprise Value | $1,469 | $1,361 | $1,289 | $1,106 |
| Revenue | $425 | $410 | $367 | $329 |
| % Growth | 3.5% | 11.9% | 11.3% | – |
| Gross Profit | $394 | $378 | $333 | $294 |
| % Margin | 92.7% | 92.2% | 90.9% | 89.3% |
| EBITDA | $56 | $225 | -$10 | $21 |
| % Margin | 13.2% | 54.7% | -2.8% | 6.4% |
| Net Income | -$59 | $104 | -$132 | -$87 |
| % Margin | -14% | 25.4% | -35.9% | -26.3% |
| EPS Diluted | -2.94 | 5.11 | -6.29 | -4.13 |
| % Growth | -157.5% | 181.2% | -52.3% | – |
| Operating Cash Flow | $132 | $39 | $12 | $22 |
| Capital Expenditures | -$44 | -$46 | -$42 | -$29 |
| Free Cash Flow | $88 | -$7 | -$30 | -$7 |